AGP Picks
View all

AI oncology analytics market seen reaching $6.26 billion by 2030

Oct. 30, 2026
AI oncology analytics market seen reaching $6.26 billion by 2030
By AI, Created 16:30 UTC, Oct 30, 2026, AGP -

The Business Research Company says the market for AI in oncology analytical solutions will rise from $1.44 billion in 2025 to $6.26 billion by 2030, driven by cancer growth, better AI tools and wider clinical use. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - AI tools for oncology could speed up cancer research, improve diagnosis and support more personalized treatment planning. - The market’s projected jump to $6.26 billion by 2030 signals broader adoption of AI across cancer care workflows. - Rising global cancer incidence is increasing demand for faster analytics, better diagnostics and data-driven treatment decisions.

What happened: - The Business Research Company published its AI in Oncology for Analytical Solutions Global Market Report 2026 on Oct. 30, 2026. - The report estimates the market will grow from $1.44 billion in 2025 to $1.93 billion in 2026. - The report projects the market will reach $6.26 billion by 2030, at a 34.2% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth over the forecast period.

The details: - AI in oncology analytical solutions use artificial intelligence to support cancer research, diagnosis and therapy planning. - The tools are designed to help healthcare professionals make data-driven decisions, improve diagnostic precision and tailor treatment plans. - Historical growth was linked to limited earlier adoption of AI in oncology, reliance on traditional diagnostic methods, a rising cancer burden, expanding clinical research and stronger demand for tailored treatments. - Future growth is expected to come from better oncology-specific AI algorithms, growth in oncology data licensing services, stronger use of genomic data, wider adoption of clinical decision support software and more collaboration between healthcare providers and AI vendors. - Emerging trends include AI-powered imaging and diagnostic tools, predictive analytics in cancer research, expanded decision support for treatment planning, integration of genomic insights with therapies and higher demand for data licensing and analytics services. - The report highlights market analysis across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also says its 2026 editions include market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspots infographics, and updated graphics and tables. - Download a free sample of the report. - View the full market report.

Between the lines: - The forecast suggests oncology AI is moving from niche use toward a more established role in clinical and research settings. - The emphasis on genomics, decision support and data licensing points to a market that is expanding beyond standalone software into broader healthcare data infrastructure. - The geographic split suggests mature health systems are driving current revenue, while faster adoption in Asia-Pacific could reshape the market mix over time.

What's next: - More hospitals, researchers and vendors are likely to invest in oncology AI tools as cancer data volumes grow. - Market growth will likely depend on how quickly healthcare systems integrate AI with imaging, genomics and clinical decision support. - Wider collaboration between providers and AI vendors could accelerate commercialization and deployment across regions.

The bottom line: - Oncology AI analytics is forecast to remain one of the faster-growing healthcare technology markets through 2030.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

IT Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

IT Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.